Skip to content
Abierto
Menu

Combined synopsis and solicitation, first published as presolicitation

Trastuzumab and Biosimilars (VA-25-00052526)

36E79725R0038

Department of Veterans Affairs, Nac Pharmaceuticals. Pharmaceutical Preparation Manufacturing.

View on SAM.govMarkdown

Awarded

Amgen USA Inc.

$0.00 obligated so far on USAspending

Description

As published on SAM.gov.

Trastuzumab and Biosimilars (VA-25-00052526)

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Amgen USA Inc.
UEI
XPGNQMXHP493
CAGE
5YNZ4
Vendor location
Newbury Park, CA
Contract
36E79725D0053
Obligated
$0.00, potential $15,375,050
Actions
5 between September 2, 2025 and March 11, 2026
Competition
Full and Open Competition, 3 offers received
Set-aside reported
No Set Aside Used.
Described as
New Award for Trastuzumab with Amgen. Ordering Period Is Nov 15, 2025 Through Nov 14, 2026 with Four ONE-YEAR Options.
Match
solicitation number 36E79725R0038 equals the FPDS solicitation identifier; same awarding office 36E797 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. May 1, 2025

    Presolicitation

    Trastuzumab and Biosimilars

    Due June 4, 2025 at 3:30 PM EDT. SAM.gov, notice 4b4a7b65285a48b69426c97ede3d94f6

  2. June 23, 2025

    Combined synopsis and solicitation, originally presolicitation

    Due July 8, 2025 at 3:30 PM EDT. SAM.gov, notice 00d4073898f94e27bd7e54e2a2069cb2

  3. July 8, 2025

    Combined synopsis and solicitation

    Due July 15, 2025 at 3:30 PM EDT. SAM.gov, notice 8fc22c111bc84d0a9f7f95b421cf47c6

Points of contact

Also open from this buyer